Tender Details

Country: Germany
Summary: Openhouse Procedure - Div. Active Ingredients from October 1St, 2022
DET Ref No: 81875982
Deadline: 31 Aug 2024
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 232517-2023
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Conclusion of non-exclusive discount agreements according to § 130 a paragraph 8 SGB V with the possibility of conclusion at any time as part of the so-called "Open House procedure" for various active pharmaceutical ingredients with the earliest possible start of the contract on October 1st, 2022.
.
The specific active pharmaceutical ingredients and the respective VeContract starts can be found in the current list of active pharmaceutical ingredients in the project room of the procurement portal dtvp in the "Award documents" section.
.
As of October 1st, 2022, contracts for the following active ingredients will be offered:
.
Abacavir / lamivudine / zidovudine
Acetylcystein_non-RX non-RX
Acetylcystein_RX RX
Acetylsalicylic acid products that can only be prescribed according to Annex 1 AM-RL G-BA
Acitretin
Adefovir dipivoxil
Alitretinoin
Amifampridine
Anagrelide except N3 packs of the DAR HKP with 0.5 mg potency
Aripiprazole excluding DAR tablets/melt tablets and oral solutions
Atorvastatin/ezetimibe
beclometasone/formoterol
beclometasone/formoterol/glycopyrronium
bimatoprost
biperiden
bortezomib
brivudine
budesonide except inhalatives
calcipotriol
calcium / colecalciferol
ceftriaxone
clomipramine 75 mg strength, slow-release
clostridium botulinum except lifestyle drugs
colecalciferol non-RX
colecalciferol RX
colistin
cyproterone
deferasirox
desloratadin
desogestrel / ethinylestradiol
dienogest
dienogest / ethinylestradiol
diltiazem
distigmin
dornase alpha
dronedarone
drospirenone / ethinylestradiol
ebastine
iron II oral DAR/exclusively according to Appendix 1 AM-RL G-BA prescribe...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Openhouse Procedure - Div. Active Ingredients from October 1St, 2022 - Germany Tender

The AOK RHINELAND/HAMBURG - THE HEALTH INSURANCE FUND, a Government sector organization in Germany, has announced a new tender for Openhouse Procedure - Div. Active Ingredients from October 1St, 2022. This tender is published on GermanyTenders under DET Ref No: 81875982 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-08-31.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.